[Invitation] EClinCloud Invites You to the National Pharmaceutical Project Translation Forum

Source: EClinCloud. Author: EClinCloud.

On March 23–24, 2023, the National Pharmaceutical Project Translation Forum will be held at Chengdu Yujiang Hotel. The conference will showcase more than 50 high-potential, tradable pharmaceutical projects across areas including traditional Chinese medicine, chemical drugs, biologics, and medical devices, and will invite top 20 domestic pharmaceutical R&D service companies as well as R&D service enterprises with mature projects open to external collaboration to discuss topics including Marketing Authorization Holder (MAH) transfer, project initiation, and equity investment.
During the afternoon sub-forum on March 24, Dr. Qin Long, CEO of EClinCloud, has been invited to attend and will deliver a keynote presentation from 14:50–15:15 titled "Scale and Rating Management in Clinical Research." Starting from the concept of COA, he will detail the significance and value of scale management and rater training, and share the perspectives of global regulatory authorities on the use of eCOA. We look forward to exchanging insights and discussing with industry experts at the event!
Sub-forum: Drug R&D and Clinical Research
Presentation Time: Friday, March 24, 14:50–15:15
Presentation Topic: Scale and Rating Management in Clinical Research

Over 17 years of experience in technology applications for the clinical research industry;
An innovative and inspiring leader, and a pioneer in promoting and implementing technology solutions such as eCOA, EDC, and CTMS in China's clinical trial research sector;
Previously served as Asia-Pacific head for multiple international technology companies, leading rapid regional business growth;
An entrepreneur driven by academics and science, dedicated with strong passion to shaping new models for the future of clinical trials.

*Note: To register for the conference and obtain more information, please follow the "Yaoyou Zhijia" (药友之家) WeChat official account.
EClinCloud is a technology company focused on clinical R&D, providing an integrated, interoperable all-in-one clinical trial cloud platform (including technology products such as CTMS, eTMF, EDC, RTSM, eCOA, and eConsent, as well as solutions such as scale management, linguistic validation, rater training, and data quality analysis) along with clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, and ophthalmology). By combining cutting-edge technology with life data, EClinCloud builds a globally leading, patient-centric clinical evidence support SaaS cloud platform to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



